B lymphocyte lineage cells in newborn and very young NZB mice: evidence for regulatory disorders affecting B cell formation.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 6605377)

Published in J Immunol on November 01, 1983

Authors

H Jyonouchi, P W Kincade, R A Good, M E Gershwin

Articles by these authors

(truncated to the top 100)

In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest (1967) 10.26

Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J Clin Invest (1967) 9.01

Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man. J Exp Med (1981) 6.82

Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med (1976) 5.50

Murine B cell leukemia line with inducible surface immunoglobulin expression. J Immunol (1978) 4.93

Acute poststreptococcal glomerulonephritis: immune deposit disease. J Clin Invest (1966) 4.64

Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet (1968) 4.41

Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen. Proc Natl Acad Sci U S A (1981) 4.38

The functions of the thymus system and the bursa system in the chicken. J Exp Med (1966) 4.07

CD44 and its interaction with extracellular matrix. Adv Immunol (1993) 4.04

Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet (1966) 3.97

The IgA system. I. Studies of the transport and immunochemistry of IgA in the saliva. J Exp Med (1966) 3.97

Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med (1990) 3.78

Primary immunodeficiencies. Report of a World Health Organization Committee. Pediatrics (1971) 3.69

Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity. Am J Med (1968) 3.54

A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J Cell Biol (1991) 3.23

Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J Exp Med (1991) 3.21

Protection of phagocytized bacteria from the killing action of antibiotics. Nature (1966) 3.12

Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med (1990) 3.05

Phosphatidylinositol is the membrane-anchoring domain of the Thy-1 glycoprotein. Nature (1985) 2.97

Suppression of immunoglobulin G synthesis as a result of antibody-mediated suppression of immunoglobulin M synthesis in chickens. Proc Natl Acad Sci U S A (1970) 2.93

Antigens displayed on murine B lymphocyte precursors. J Immunol (1981) 2.91

Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol (1987) 2.90

Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells. J Exp Med (1980) 2.89

Complement activity and inflammatory neutrophil exudation in man. Studies in patients with glomerulonephritis, essential hypocomplementemia and agammaglobulinemia. Int Arch Allergy Appl Immunol (1967) 2.64

Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-beta. J Immunol (1989) 2.64

The cellular immune defect in chronic mucocutaneous candidiasis. Lancet (1969) 2.53

C2 deficiency. Development of lupus erythematosus. J Clin Invest (1973) 2.52

A newly defined X-linked trait in man with demonstration of the Lyon effect in carrier females. Lancet (1967) 2.47

Identification of stromal cell products that interact with pre-B cells. J Cell Biol (1996) 2.46

Development and distribution of immunoglobulin-containing cells in the chicken. An immunofluorescent analysis using purified antibodies to mu, gamma and light chains. J Immunol (1971) 2.46

Influence of diet on survival of mice. Proc Natl Acad Sci U S A (1976) 2.45

An NK1.1+ CD4+8- single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor V beta family. Proc Natl Acad Sci U S A (1992) 2.43

Deficient immunologic functions of NZB mice. Proc Soc Exp Biol Med (1968) 2.41

The complement profile in acute glomerulonephritis systemic lupus erythematosus and hypocomplementemic chronic glomerulonephritis. Contrasts and experimental correlations. Int Arch Allergy Appl Immunol (1968) 2.38

Effects of protein insufficiency on immune responsiveness. Am J Clin Nutr (1974) 2.37

Localization of immunological complexes fixing beta1C (C3) in germinal centers of lymph nodes. J Exp Med (1969) 2.36

Chemical suppression of adaptive immunity. Adv Immunol (1967) 2.35

Growth of a pure population of mouse mast cells in vitro with conditioned medium derived from concanavalin A-stimulated splenocytes. Proc Natl Acad Sci U S A (1981) 2.33

NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion. Eur J Immunol (1993) 2.32

The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol (1990) 2.32

Effect of antibiotics on the bactericidal activity of human leukocytes. J Lab Clin Med (1968) 2.31

Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer (1971) 2.31

Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet (1998) 2.31

Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J Exp Med (1992) 2.30

T-cell depletion of HLA-identical transplants in leukemia. Blood (1991) 2.25

Monoclonal antibody analysis of human T lymphocyte subpopulations exhibiting autologous mixed lymphocyte reaction. Proc Natl Acad Sci U S A (1981) 2.16

Suppression of B-cell differentiation by leukocytes from hypogammaglobulinemic patients. J Clin Invest (1976) 2.15

Improved tests for the evaluation of neutrophil function in human disease. J Lab Clin Med (1968) 2.11

A mammalian equivalent of the avian bursa of Fabricius. Lancet (1966) 2.11

Development and function of the immunoglobulin producing system. I. Effect of bursectomy at different stages of development on germinal centers, plasma cells, immunoglobulins and antibody production. Int Arch Allergy Appl Immunol (1969) 2.06

B29: a member of the immunoglobulin gene superfamily exclusively expressed on beta-lineage cells. Proc Natl Acad Sci U S A (1988) 2.05

Kaposi's sarcoma: a review and recent developments. CA Cancer J Clin (1981) 2.05

Ubiquitin-dependent degradation of IkappaBalpha is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1. Proc Natl Acad Sci U S A (1999) 2.04

Development of "autoimmune processes" in rabbits after neonatal removal of central lymphoid tissue. Lancet (1965) 2.04

Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. Proc Natl Acad Sci U S A (1985) 2.04

Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE. Arthritis Rheum (1977) 2.03

Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr (2001) 2.03

Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc Natl Acad Sci U S A (1985) 2.03

Restriction of surface immunoglobulin determinants to lymphocytes of the plasma cell line. J Immunol (1971) 2.01

Phytohaemagglutinin unresponsiveness of lymphocytes from babies with congenital rubella. Nature (1967) 1.99

Mechanism of action of migration inhibitory factor (MIF). I. Evidence for a receptor for MIF present on the peritoneal macrophage but not on the alveolar macrophage. J Exp Med (1972) 1.99

Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood (1983) 1.98

Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood (1990) 1.98

Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci U S A (1985) 1.97

The nephrotic syndrome of childhood: immunologic, clinical, and pathologic correlations. J Clin Invest (1966) 1.96

Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice. J Exp Med (1980) 1.94

Lung response to congenitally athymic (nude), heterozygous, and Swiss Webster mice to aerogenic and intranasal infection by Nocardia asteroides. Infect Immun (1978) 1.94

Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis). Medicine (Baltimore) (1970) 1.94

Glomerular localization and transport of aggregated proteins in mice. Lab Invest (1967) 1.94

Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement. Proc Natl Acad Sci U S A (1969) 1.92

Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat Immunol (2001) 1.91

Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation. J Exp Med (1977) 1.91

The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med (1988) 1.89

Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes. Clin Exp Immunol (1976) 1.87

The geoepidemiology of type 1 diabetes. Autoimmun Rev (2009) 1.87

Growth of B-lymphocytes clones in semisolid culture is mitogen dependent. J Exp Med (1976) 1.86

Cell-specific heterogeneity in sensitivity of phosphatidylinositol-anchored membrane antigens to release by phospholipase C. J Immunol Methods (1988) 1.85

Effect of murine cytomegalovirus on the in vitro responses of T and B cells to mitogens. J Immunol (1976) 1.84

Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83

A proposed classification of primary immunologic deficiencies. Am J Med (1968) 1.83

Decreased properdin activity in acute glomerulonephritis. Int Arch Allergy Appl Immunol (1969) 1.83

Abnormalities of in vitro lymphocyte responses during rubella virus infections. J Exp Med (1968) 1.82

Pneumocystis carinii infection. Medicine (Baltimore) (1973) 1.79

Hypothalamic-pituitary-adrenal axis suppression associated with the use of inhaled fluticasone propionate. J Allergy Clin Immunol (1998) 1.77

Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice. J Exp Med (1989) 1.77

Subpopulations of human T lymphocytes. II. Effect of thymopoietin, corticosteroids, and irradiation. Cell Immunol (1977) 1.76

Role of the thymus and other central lymphoid tissues in immunological disease. Annu Rev Med (1967) 1.76

Hereditary C2 deficiency: Genetic studies and association with the HL-A system. J Exp Med (1975) 1.75

Monoclonal rat antibodies to murine IgM determinants. J Immunol Methods (1981) 1.75

Absence of enhancing antibody in cell mediated immunity to tumour heterografts in protein deficient rats. Nature (1971) 1.74

N.B.T. test stimulated. Lancet (1970) 1.73

B and T lymphocytes in primary immunodeficiency disease in man. J Clin Invest (1973) 1.72

Ontogeny of lymphocyte subpopulations in human fetal liver. Proc Natl Acad Sci U S A (1976) 1.71

Biosynthesis and secretion of immunoglobulins by peripheral-blood lymphocytes in severe hypogammaglobulinaemia. Lancet (1972) 1.71

Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet (1981) 1.70

Subpopulations of human T lymphocytes. I. Studies in immunodeficient patients. Clin Exp Immunol (1977) 1.69

Autoimmune phenomena and renal disease in mice. Role of thymectomy, aging, and involution of immunologic capacity. Lab Invest (1970) 1.69

Lymphoid tissue abnormalities associated with ataxia-telangiectasia. Am J Med (1966) 1.69

The fate of fetal and adult B-cell progenitors grafted into immunodeficient CBA/N mice. J Exp Med (1979) 1.68